Regulatory function of recombinant human bone morphogenetic protein 2 and basic fibroblast growth factor in the induced osteogenesis and their regulatory mechanisms
杜俊杰,罗卓荆,胡蕴玉,李明全,袁志,曹艳杰,崔庚,李丹,吕荣,王建波
DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.08.020
2004-01-01
Abstract:Aim: To detect the changes and changing rules of type I, II collagen mRNA expression with in situ hybridization, and to assay the activity of alkaline phosphatase(ALP) in the bone tissue so as to analyze the regulatory function of bone morphogenetic protein 2 (rhBMP-2) and basic fibroblast growth factor (bFGF) during osteogenesis and their regulatory mechanisms. Methods: Totally 110 BALB/c mice were randomly divided into two groups by throwing coins(55 in each group). Mice receiving rhBMP-2/bFGF served as the trial group and those receiving rhBMP-2 served as the control group. In order to detect the expression of collagen I, II mRNA and ALP in osteogenesis induced by rhBMP-2/ bFGF and rhBMP-2, in situ hybridization analysis was performed at 3, 5, 7, 9, 11, 14, 17 and 21 days after the implantation. Meanwhile, ALP activity was analyzed quantitatively, and the expression of collagen I, II mRNA and ALP was observed. Results: 1 The formation of type II collagen mRNA was accompanied by that of chondroblasts and chondrocytes. 2 Type I collagen mRNA and ALP, markers of osteoblast differentiation, were expressed at the early stage of chondrogenesis, but type I collagen mRNA was still expressed at higher level, and ALP decreased gradually with the formation of osteoblasts and osteogenesis. 3 Expression of collagen I, 11 mRNA and ALP in the trial group was higher than that in the control group, ALP was (63.85 ± 6.87), (27.12 ± 4.23) and (8.93 ± 1.49) IU/g in the trial group and (27.26 ± 4.13), (70.65 ± 5.92), (39.46 ± 4.72) IU/g in the control group(t = 12.40, 20.85, 17.52, P < 0.01) respectively at 14, 17 and 21 days after the implantation. Conclusion: bFGF enhances the expression of collagen I, II mRNA and ALP in osteogenesis induced by rhBMP-2.